Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis

Results from the Sister Study

Sangmi Kim, Dale P. Sandler, Gleta Carswell, Lisa A. De Roo, Christine G. Parks, Richard Cawthon, Clarice R. Weinberg, Jack A. Taylor

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objective: Telomeres are required for maintaining genomic integrity and may play a role in carcinogenesis. Some, but not all, epidemiologic studies have found that short telomeres in leukocytes are associated with an increased risk of breast cancer. To further elucidate this potential association, we examined telomere length in relation to breast cancer risk in prospectively collected blood samples from the Sister Study, a cohort of women aged 35-74 years who have a sister with breast cancer. Methods: We performed a case-cohort analysis comparing incident breast cancer cases (n = 342) with a subcohort (n = 735), randomly selected from 29,026 participants, enrolled by June 1, 2007. Relative telomere length in peripheral blood cells was estimated using a single-tube monochrome multiplex quantitative PCR assay. Results: No association was observed between telomere length and breast cancer risk. Compared with the longest quartile, hazard ratios (HR) associated with the second, third, and the shortest quartile were 0.91 [95% confidence interval (95% CI): 0.62-1.34], 1.11 (95% CI: 0.77-1.60), and 0.93 (95% CI: 0.64-1.35), respectively. Subgroup analyses by menopausal status, invasiveness, or estrogen receptor status of breast cancer did not reveal evidence of association between telomere length in blood cells and subsequent breast cancer risk. Conclusions: This prospective investigation does not support telomere length in blood cells as a biomarker for breast cancer risk.

Original languageEnglish (US)
Pages (from-to)1061-1066
Number of pages6
JournalCancer Causes and Control
Volume22
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

Telomere
Siblings
Cohort Studies
Breast Neoplasms
Blood Cells
Confidence Intervals
Multiplex Polymerase Chain Reaction
Estrogen Receptors
Epidemiologic Studies
Carcinogenesis
Leukocytes
Biomarkers

Keywords

  • Biomarker
  • Breast cancer
  • Prospective study
  • Telomere length
  • qPCR

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kim, S., Sandler, D. P., Carswell, G., De Roo, L. A., Parks, C. G., Cawthon, R., ... Taylor, J. A. (2011). Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: Results from the Sister Study. Cancer Causes and Control, 22(7), 1061-1066. https://doi.org/10.1007/s10552-011-9778-8

Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis : Results from the Sister Study. / Kim, Sangmi; Sandler, Dale P.; Carswell, Gleta; De Roo, Lisa A.; Parks, Christine G.; Cawthon, Richard; Weinberg, Clarice R.; Taylor, Jack A.

In: Cancer Causes and Control, Vol. 22, No. 7, 01.07.2011, p. 1061-1066.

Research output: Contribution to journalArticle

Kim, S, Sandler, DP, Carswell, G, De Roo, LA, Parks, CG, Cawthon, R, Weinberg, CR & Taylor, JA 2011, 'Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: Results from the Sister Study', Cancer Causes and Control, vol. 22, no. 7, pp. 1061-1066. https://doi.org/10.1007/s10552-011-9778-8
Kim, Sangmi ; Sandler, Dale P. ; Carswell, Gleta ; De Roo, Lisa A. ; Parks, Christine G. ; Cawthon, Richard ; Weinberg, Clarice R. ; Taylor, Jack A. / Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis : Results from the Sister Study. In: Cancer Causes and Control. 2011 ; Vol. 22, No. 7. pp. 1061-1066.
@article{b5bf0819d2a0495e8587ee74d46aac03,
title = "Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: Results from the Sister Study",
abstract = "Objective: Telomeres are required for maintaining genomic integrity and may play a role in carcinogenesis. Some, but not all, epidemiologic studies have found that short telomeres in leukocytes are associated with an increased risk of breast cancer. To further elucidate this potential association, we examined telomere length in relation to breast cancer risk in prospectively collected blood samples from the Sister Study, a cohort of women aged 35-74 years who have a sister with breast cancer. Methods: We performed a case-cohort analysis comparing incident breast cancer cases (n = 342) with a subcohort (n = 735), randomly selected from 29,026 participants, enrolled by June 1, 2007. Relative telomere length in peripheral blood cells was estimated using a single-tube monochrome multiplex quantitative PCR assay. Results: No association was observed between telomere length and breast cancer risk. Compared with the longest quartile, hazard ratios (HR) associated with the second, third, and the shortest quartile were 0.91 [95{\%} confidence interval (95{\%} CI): 0.62-1.34], 1.11 (95{\%} CI: 0.77-1.60), and 0.93 (95{\%} CI: 0.64-1.35), respectively. Subgroup analyses by menopausal status, invasiveness, or estrogen receptor status of breast cancer did not reveal evidence of association between telomere length in blood cells and subsequent breast cancer risk. Conclusions: This prospective investigation does not support telomere length in blood cells as a biomarker for breast cancer risk.",
keywords = "Biomarker, Breast cancer, Prospective study, Telomere length, qPCR",
author = "Sangmi Kim and Sandler, {Dale P.} and Gleta Carswell and {De Roo}, {Lisa A.} and Parks, {Christine G.} and Richard Cawthon and Weinberg, {Clarice R.} and Taylor, {Jack A.}",
year = "2011",
month = "7",
day = "1",
doi = "10.1007/s10552-011-9778-8",
language = "English (US)",
volume = "22",
pages = "1061--1066",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis

T2 - Results from the Sister Study

AU - Kim, Sangmi

AU - Sandler, Dale P.

AU - Carswell, Gleta

AU - De Roo, Lisa A.

AU - Parks, Christine G.

AU - Cawthon, Richard

AU - Weinberg, Clarice R.

AU - Taylor, Jack A.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objective: Telomeres are required for maintaining genomic integrity and may play a role in carcinogenesis. Some, but not all, epidemiologic studies have found that short telomeres in leukocytes are associated with an increased risk of breast cancer. To further elucidate this potential association, we examined telomere length in relation to breast cancer risk in prospectively collected blood samples from the Sister Study, a cohort of women aged 35-74 years who have a sister with breast cancer. Methods: We performed a case-cohort analysis comparing incident breast cancer cases (n = 342) with a subcohort (n = 735), randomly selected from 29,026 participants, enrolled by June 1, 2007. Relative telomere length in peripheral blood cells was estimated using a single-tube monochrome multiplex quantitative PCR assay. Results: No association was observed between telomere length and breast cancer risk. Compared with the longest quartile, hazard ratios (HR) associated with the second, third, and the shortest quartile were 0.91 [95% confidence interval (95% CI): 0.62-1.34], 1.11 (95% CI: 0.77-1.60), and 0.93 (95% CI: 0.64-1.35), respectively. Subgroup analyses by menopausal status, invasiveness, or estrogen receptor status of breast cancer did not reveal evidence of association between telomere length in blood cells and subsequent breast cancer risk. Conclusions: This prospective investigation does not support telomere length in blood cells as a biomarker for breast cancer risk.

AB - Objective: Telomeres are required for maintaining genomic integrity and may play a role in carcinogenesis. Some, but not all, epidemiologic studies have found that short telomeres in leukocytes are associated with an increased risk of breast cancer. To further elucidate this potential association, we examined telomere length in relation to breast cancer risk in prospectively collected blood samples from the Sister Study, a cohort of women aged 35-74 years who have a sister with breast cancer. Methods: We performed a case-cohort analysis comparing incident breast cancer cases (n = 342) with a subcohort (n = 735), randomly selected from 29,026 participants, enrolled by June 1, 2007. Relative telomere length in peripheral blood cells was estimated using a single-tube monochrome multiplex quantitative PCR assay. Results: No association was observed between telomere length and breast cancer risk. Compared with the longest quartile, hazard ratios (HR) associated with the second, third, and the shortest quartile were 0.91 [95% confidence interval (95% CI): 0.62-1.34], 1.11 (95% CI: 0.77-1.60), and 0.93 (95% CI: 0.64-1.35), respectively. Subgroup analyses by menopausal status, invasiveness, or estrogen receptor status of breast cancer did not reveal evidence of association between telomere length in blood cells and subsequent breast cancer risk. Conclusions: This prospective investigation does not support telomere length in blood cells as a biomarker for breast cancer risk.

KW - Biomarker

KW - Breast cancer

KW - Prospective study

KW - Telomere length

KW - qPCR

UR - http://www.scopus.com/inward/record.url?scp=79960264057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960264057&partnerID=8YFLogxK

U2 - 10.1007/s10552-011-9778-8

DO - 10.1007/s10552-011-9778-8

M3 - Article

VL - 22

SP - 1061

EP - 1066

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 7

ER -